跳至主要内容
临床试验/NCT07767838
NCT07767838已完成不适用

Nipple Reinnervation in Two-stage Alloplastic Breast Reconstruction.

Hospital Angeles del Pedregal1 个研究点 分布在 1 个国家目标入组 18 人开始时间: 2021年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
18
试验地点
1
主要终点
Sensory evaluation was performed in each zone using the British Medical Research Council (BMRC) scale

研究概览

简要总结

A prospective study was conducted including patients undergoing nipple-sparing mastectomy with neurotization during expander-to-implant exchange between 2021 and 2025.

详细描述

The investigators conducted a prospective study including consecutive patients undergoing nipple-sparing mastectomy (NSM) with nipple neurotization at the time of expander-to-implant exchange between 2021 and 2025.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Adult female patients (≥18 years of age).
  • Patients who underwent nipple-sparing mastectomy (NSM) with immediate tissue-expander placement.
  • Patients undergoing nipple neurotization at the time of expander-to-implant exchange.
  • Patients with a clinically viable nipple-areola complex (NAC) at the time of neurotization.
  • Patients who underwent standardized sensory assessment of the breast/NAC preoperatively and at least one postoperative time point.
  • Patients who provided informed consent for participation and postoperative sensory assessment.

排除标准

  • Patients younger than 18 years of age.
  • Male patients.
  • Patients who underwent a mastectomy other than nipple-sparing mastectomy.
  • Patients who underwent nipple neurotization at a time other than the expander-to-implant exchange.
  • Patients unable to undergo standardized sensory testing or unable to reliably report sensory perception.
  • Patients without adequate postoperative follow-up to perform the required sensory assessments.
  • Patients who declined participation or withdrew consent.

研究组 & 干预措施

Surgery

Experimental

干预措施: Nipple neurotization (Procedure)

结局指标

主要结局

Sensory evaluation was performed in each zone using the British Medical Research Council (BMRC) scale

时间窗: 1 year

Sensory recovery will be assessed using the British Medical Research Council Sensory Scale, which grades sensory function from S0 to S4. S0 represents complete absence of sensation, while S4 represents normal sensation. The scale includes intermediate grades (S1, S2, S2+, S3, and S3+) reflecting progressive recovery of pain, tactile sensation, and two-point discrimination. The minimum value is S0 and the maximum value is S4; higher scores indicate better sensory recovery.

Sensory evaluation was performed in each zone using the Semmes-Weinstein monofilament test.

时间窗: 1 year

Sensory function will be assessed using Semmes-Weinstein monofilament testing with the Baseline Tactile Monofilament Test Kit, consisting of monofilaments calibrated to apply forces of 0.07 g, 0.4 g, 2.0 g, 4.0 g, and 300 g. The lowest force detected by the participant will be recorded as the sensory threshold. A lower detection threshold indicates better sensory function, with 0.07 g representing the best possible result and failure to detect the 300 g monofilament representing the worst possible result.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jose Eduardo Telich Tarriba

Plastic Surgeon

Hospital Angeles del Pedregal

研究点 (1)

Loading locations...

相似试验